Common drug may shield cancer patients from Chemo's agonizing nerve damage
NCT ID NCT07025005
Summary
This study is testing if fenofibrate, a drug usually used for high cholesterol, can help prevent or reduce nerve pain (peripheral neuropathy) caused by a standard chemotherapy combination for multiple myeloma. It will involve 44 newly diagnosed patients, with half receiving the standard chemo and half receiving the chemo plus fenofibrate. Researchers will measure nerve pain levels and specific blood markers to see if the added drug makes a difference.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL NEUROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Damanhur Oncology Center
RECRUITINGDamanhur, El- Behira, Egypt
-
Tanta University
RECRUITINGTanta, El-Gharbya, Egypt
Conditions
Explore the condition pages connected to this study.